Abstract

SummaryBackgroundCNS infections are a leading cause of HIV-related deaths in sub-Saharan Africa, but causes and outcomes are poorly defined. We aimed to determine mortality and predictors of mortality in adults evaluated for meningitis in Botswana, which has an estimated 23% HIV prevalence among adults.MethodsIn this prevalent cohort study, patient records from 2004–15 were sampled from the Botswana national meningitis survey, a nationwide audit of all cerebrospinal fluid (CSF) laboratory records from patients receiving a lumbar puncture for evaluation of meningitis. Data from all patients with culture-confirmed pneumococcal and tuberculous meningitis, and all patients with culture-negative meningitis with CSF white cell count (WCC) above 20 cells per μL were included in our analyses, in addition to a random selection of patients with culture-negative CSF and CSF WCC of up to 20 cells per μL. We used patient national identification numbers to link CSF laboratory records from the national meningitis survey to patient vital registry and HIV databases. Univariable and multivariable Cox proportional hazards models were used to evaluate clinical and laboratory predictors of mortality.FindingsWe included data from 238 patients with culture-confirmed pneumococcal meningitis, 48 with culture-confirmed tuberculous meningitis, and 2900 with culture-negative CSF (including 1691 with CSF WCC of up to 20 cells per μL and 1209 with CSF WCC above 20 cells per μL). Median age was 37 years (IQR 31–46), 1605 (50%) of 3184 patients were male, 2188 (72%) of 3023 patients with registry linkage had documentation of HIV infection, and median CD4 count was 139 cells per μL (IQR 63–271). 10-week and 1-year mortality was 47% (112 of 238) and 49% (117 of 238) for pneumococcal meningitis, 46% (22 of 48) and 56% (27 of 48) for tuberculous meningitis, and 41% (1181 of 2900) and 49% (1408 of 2900) for culture-negative patients. When the analysis of patients with culture-negative CSF was restricted to those with known HIV infection, WCC (0–20 cells per μL vs >20 cells per μL) was not predictive of mortality (average hazard ratio 0·93, 95% CI 0·80–1·09).InterpretationMortality from pneumococcal, tuberculous, and culture-negative meningitis was high in this setting of high HIV prevalence. There is an urgent need for improved access to diagnostics, to better define aetiologies and develop novel diagnostic tools and treatment algorithms.FundingNational Institutes of Health, President's Emergency Plan for AIDS Relief, National Institute for Health Research.

Highlights

  • 409 (65%) of the 29 704 cerebrospinal fluid (CSF) records included in the Botswana national meningitis survey were in Integrated Patient Management System (IPMS) and sampled for this analysis

  • India ink and fungal cultures are routinely done, Cryptococcal antigen (CrAg) testing was done on only 703 (4%) of 19 409 samples registered on IPMS during the study period

  • CD4 cell count was measured within 6 months of lumbar puncture in 1578 (75%) of these 2109 HIV-positive individuals, with a median 136 cells per μL (IQR 61–266). 956 (45%) of 2109 patients with known HIV were on Antiretroviral therapy (ART) by the date of lumbar puncture; 615 (64%) of these 956 had a documented ART start date in IPMS, and 341 (36%) were classified as being on ART based on previous viral load testing

Read more

Summary

Introduction

CNS infections are a leading cause of mortality in sub-Saharan Africa. The emergence of HIV markedly altered the epidemiology of meningitis in the region; cryptococcal meningitis, tuberculous meningitis, and bacterial meningitis caused by Streptococcus pneumoniae are the most common confirmed causes in adults in central, east, and, southern Africa. Outcomes from cryptococcal meningitis have been relatively well described in clinical trials and observational studies. data regarding long-term outcomes from tuberculous or pneumococcal meningitis in routine-care settings are limited.5,10,11most patients with suspected meningitis evaluated by lumbar puncture and cerebrospinal fluid (CSF) analysis in resource-limited settings have no pathogen identified through diagnostic studies. Even in studies that have used enhanced molecular diagnostics, up to half of patients still did not have a definitive micro­ biological diagnosis. The aetiology of CNS infections remains poorly understood, manage­ment recommendations for this large patient population are lacking, and no data exist on short-term or long-term survival. CNS infections are a leading cause of mortality in sub-Saharan Africa.. The emergence of HIV markedly altered the epidemiology of meningitis in the region; cryptococcal meningitis, tuberculous meningitis, and bacterial meningitis caused by Streptococcus pneumoniae are the most common confirmed causes in adults in central, east, and, southern Africa.. Outcomes from cryptococcal meningitis have been relatively well described in clinical trials and observational studies.. Data regarding long-term outcomes from tuberculous or pneumococcal meningitis in routine-care settings are limited.. Most patients with suspected meningitis evaluated by lumbar puncture and cerebrospinal fluid (CSF) analysis in resource-limited settings have no pathogen identified through diagnostic studies.. The aetiology of CNS infections remains poorly understood, manage­ment recommendations for this large patient population are lacking, and no data exist on short-term or long-term survival

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call